IIM
ALDX icon

INTECH Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History

INTECH Investment Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,754
Closed -$24.9K – 2115
2026
Q1 		$24.9K Sell
14,754
-18,574
-56% -$81.4K ﹤0.01% 2060
2025
Q4 		$173K Buy
33,328
+12,117
+57% +$62.2K ﹤0.01% 2034
2025
Q3 		$111K Sell
21,211
-8,772
-29% -$45.7K ﹤0.01% 2234
2025
Q2 		$115K Buy
29,983
+6,477
+28% +$16.7K ﹤0.01% 2261
2025
Q1 		$135K Sell
23,506
-300
-1% -$1.77K ﹤0.01% 2227
2024
Q4 		$119K Buy
23,806
+9,178
+63% +$47.1K ﹤0.01% 2174
2024
Q3 		$78.8K Buy
+14,628
New +$69.6K ﹤0.01% 1929

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

INTECH Investment Management's ALDX Position: Q2 2026 in Review

INTECH Investment Management sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 14,754 shares — an estimated $24.9K sold.

INTECH Investment Management first reported a position in ALDX in Q3 2024 and held it in 7 quarters. The position peaked at $173K in Q4 2025. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • INTECH Investment Management reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 14,754 Aldeyra Therapeutics shares in Q2 2026, an estimated $24.9K.
  • INTECH Investment Management first reported a position in Aldeyra Therapeutics in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Aldeyra Therapeutics position peaked at $173K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.